Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (351-360 of 420) with videos related to

Pageof 42
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 31, 2022
Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018-2020)Helio S Sader, Mariana Castanheira, Michael D Huband, et al.
Diagnostic Microbiology and Infectious Disease|April 15, 2023
Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018-2022)Helio S Sader, Rodrigo E Mendes, Leonard Duncan, et al.
Journal of Chemotherapy (Florence, Italy)|May 14, 2019
Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014-2015)Michael A Pfaller, Helio S Sader, Dee Shortridge, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2007
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospitalRodrigo E Mendes, Mariana Castanheira, Mark A Toleman, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance ProgramRodrigo E Mendes, Mark A Toleman, Julival Ribeiro, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2016
In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from U.S. Medical Centers by Census Region, 2014Michael D Huband, Mariana Castanheira, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015-2016 and Characterization of Resistance MechanismsRodrigo E Mendes, Susanne Paukner, Timothy B Doyle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2024
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility TestingThomas P Lodise, Sujata M Bhavnani, Paul G Ambrose, et al.
The Journal of Antimicrobial Chemotherapy|March 22, 2006
Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004)Amy A Watters, Ronald N Jones, Jennifer A Leeds, et al.
Pageof 42

Showing results (351-360 of 420) with videos related to

Sort By:
Pageof 42
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 31, 2022
Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018-2020)Helio S Sader, Mariana Castanheira, Michael D Huband, et al.
Diagnostic Microbiology and Infectious Disease|April 15, 2023
Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018-2022)Helio S Sader, Rodrigo E Mendes, Leonard Duncan, et al.
Journal of Chemotherapy (Florence, Italy)|May 14, 2019
Activity of tedizolid against gram-positive clinical isolates causing infections in Europe and surrounding areas (2014-2015)Michael A Pfaller, Helio S Sader, Dee Shortridge, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2007
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospitalRodrigo E Mendes, Mariana Castanheira, Mark A Toleman, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance ProgramRodrigo E Mendes, Mark A Toleman, Julival Ribeiro, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2016
In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from U.S. Medical Centers by Census Region, 2014Michael D Huband, Mariana Castanheira, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013Helio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015-2016 and Characterization of Resistance MechanismsRodrigo E Mendes, Susanne Paukner, Timothy B Doyle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2024
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility TestingThomas P Lodise, Sujata M Bhavnani, Paul G Ambrose, et al.
The Journal of Antimicrobial Chemotherapy|March 22, 2006
Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004)Amy A Watters, Ronald N Jones, Jennifer A Leeds, et al.
Pageof 42